• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

癌症诊断年龄与临床试验参与的关联。

Association of Age at Cancer Diagnosis and Clinical Trial Participation.

机构信息

Department of Acute and Specialty Care, University of Virginia School of Nursing, Charlottesville.

Department of Pediatrics, University of Virginia School of Medicine, Charlottesville.

出版信息

JAMA Netw Open. 2021 Feb 1;4(2):e2037573. doi: 10.1001/jamanetworkopen.2020.37573.

DOI:10.1001/jamanetworkopen.2020.37573
PMID:33599770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7893497/
Abstract

This cross-sectional study uses data from the 2016 Behavioral Risk Factor Surveillance System data set to examine the association of age at cancer diagnosis with patients’ participation in clinical trials among cancer survivors.

摘要

本横断面研究使用了 2016 年行为风险因素监测系统数据集的数据，旨在探讨癌症患者的诊断年龄与癌症幸存者参与临床试验之间的关联。

相似文献

1
Association of Age at Cancer Diagnosis and Clinical Trial Participation.癌症诊断年龄与临床试验参与的关联。
JAMA Netw Open. 2021 Feb 1;4(2):e2037573. doi: 10.1001/jamanetworkopen.2020.37573.
2
Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials.可得、易接近、知晓、恰当、可接受：提高青少年和青年癌症试验参与度的策略。
Lancet Oncol. 2014 Jul;15(8):e341-50. doi: 10.1016/S1470-2045(14)70113-5.
3
Dynamics and Challenges of Clinical Trials in Adolescents and Young Adults With Cancer.青少年和青年癌症患者临床试验的动态与挑战
Cancer J. 2018 Nov/Dec;24(6):307-314. doi: 10.1097/PPO.0000000000000347.
4
Clinical trial participation by adolescents and young adults with cancer: A continued cause for concern?青少年和青年癌症患者参与临床试验：持续令人担忧？
Semin Oncol. 2018 Oct;45(5-6):275-283. doi: 10.1053/j.seminoncol.2018.04.002. Epub 2018 Apr 30.
5
Factors associated with biomedical research participation within community-based samples across 3 National Cancer Institute-designated cancer centers.与三个美国国家癌症研究所指定癌症中心的社区样本中参与生物医学研究相关的因素。
Cancer. 2020 Mar 1;126(5):1077-1089. doi: 10.1002/cncr.32487. Epub 2020 Jan 7.
6
Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study.患者收入水平与癌症临床试验参与情况：一项前瞻性调查研究
JAMA Oncol. 2016 Jan;2(1):137-9. doi: 10.1001/jamaoncol.2015.3924.
7
Position paper by the UKCCCR elderly cancer patients in clinical trials working group.英国癌症协作临床试验组老年癌症患者工作组立场文件
Br J Cancer. 2000 Jan;82(1):1-3. doi: 10.1054/bjoc.1999.0866.
8
A population-level investigation of cancer clinical trials participation in a UK region.对英国某地区癌症临床试验参与情况的人群层面调查。
Eur J Cancer Prev. 2017 Sep;26 Joining forces for better cancer registration in Europe:S229-S235. doi: 10.1097/CEJ.0000000000000373.
9
Identifying motivations and barriers to patient participation in clinical trials.确定患者参与临床试验的动机和障碍。
J Cancer Educ. 2006 Winter;21(4):237-42. doi: 10.1080/08858190701347838.
10
Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.了解老年人对参与癌症临床试验的态度。
BMC Cancer. 2006 Feb 8;6:34. doi: 10.1186/1471-2407-6-34.

引用本文的文献

1
Engagement in cancer clinical trials among a nationally representative cancer survivor sample: Motivators, barriers and opportunities for improvement.全国代表性癌症幸存者样本中参与癌症临床试验的情况：动机、障碍及改进机会。
Tumori. 2025 Aug;111(4):349-359. doi: 10.1177/03008916251347175. Epub 2025 Jun 12.
2
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer.PD-1 与 PD-L1 抑制剂免疫相关毒性的差异：一项晚期癌症患者的回顾性队列研究。
Cancer Immunol Immunother. 2024 Nov 7;74(1):14. doi: 10.1007/s00262-024-03869-1.
3
Evolution of Colorectal Cancer Trends and Treatment Outcomes: A Comprehensive Retrospective Analysis (2019-2023) in West Kazakhstan.西哈萨克斯坦 2019-2023 年结直肠癌趋势和治疗结果的演变：一项全面的回顾性分析
Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2773-2785. doi: 10.31557/APJCP.2024.25.8.2773.
4
Facilitators and Barriers to Older Adult Participation in Cancer Trials: A Qualitative Study Exploring Patient-Caregiver Dyad Congruence.促进和阻碍老年癌症患者参与临床试验的因素：一项定性研究探索患者-照顾者二元组的一致性。
JCO Oncol Pract. 2023 Jul;19(7):484-492. doi: 10.1200/OP.22.00843. Epub 2023 Apr 20.
5
Validation of a Population-Based Data Source to Examine National Cancer Clinical Trial Participation.基于人群的数据源验证，以考察全国癌症临床试验参与情况。
JAMA Netw Open. 2022 Mar 1;5(3):e223687. doi: 10.1001/jamanetworkopen.2022.3687.
6
Age Differences in Clinical Trial Understanding in Non-Hodgkin Lymphoma Patients.非霍奇金淋巴瘤患者临床试验理解的年龄差异。
Clin Lymphoma Myeloma Leuk. 2022 Jul;22(7):e549-e554. doi: 10.1016/j.clml.2022.02.003. Epub 2022 Feb 22.

本文引用的文献

1
Older adult participation in cancer clinical trials: A systematic review of barriers and interventions.老年人参与癌症临床试验：障碍和干预措施的系统评价。
CA Cancer J Clin. 2021 Jan;71(1):78-92. doi: 10.3322/caac.21638. Epub 2020 Oct 1.
2
Modernizing Clinical Trial Eligibility: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research Minimum Age Working Group.现代化临床试验资格标准：美国临床肿瘤学会-癌症研究之友最低年龄工作组的建议
J Clin Oncol. 2017 Nov 20;35(33):3781-3787. doi: 10.1200/JCO.2017.74.4144. Epub 2017 Oct 2.
3
Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults.美国青少年和青年成年人与儿童及老年人癌症生存趋势的比较。
Cancer. 2016 Apr 1;122(7):1009-16. doi: 10.1002/cncr.29869. Epub 2016 Feb 5.
4
Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.在一家美国国立癌症研究所指定的综合癌症中心对青少年和青年成人临床试验入组情况进行病例关联分析。
Cancer. 2015 Dec 15;121(24):4398-406. doi: 10.1002/cncr.29669. Epub 2015 Sep 22.
5
Does enrollment in cancer trials improve survival?癌症临床试验的参与是否能改善生存？
J Am Coll Surg. 2013 Apr;216(4):774-80; discussion 780-1. doi: 10.1016/j.jamcollsurg.2012.12.036. Epub 2013 Feb 13.